Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0011860 (
type 2 diabetes
)
57,723
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Trigger
finger is a stenosing tenovaginitis in which there is a constriction of the annular sheath associated with a nodule in the digital flexor tendon. Clinically this can present as triggering or snapping of the nodule as it passes through the tight constricting tendon sheath. Although many triggering fingers settle spontaneously, and others respond to local anesthetic and steroid injection, others require surgical decompression. The association between diabetes and trigger finger, although not widely known, has been described and forms part of the "diabetic hand syndrome". We studied 100 adult patients in the group that required surgery. Eighteen of the 100 patients were diabetic with six insulin dependent diabetics (IDDM) and 12 non-insulin dependent diabetics (
NIDDM
). In the current climate of day case surgery this has significant implications both for the management of known diabetics as well as the preoperative detection of those with the condition.
...
PMID:Diabetes and trigger finger. 975 37
Objective:
To evaluate the potential association between the genetic variants in miRNA processing genes (
RAN
, XPO5, DICER1
, and
TARBP2
) and susceptibility to
type 2 diabetes
mellitus (T2DM) and its vascular complications, as well as to further investigate their interaction with environmental factors in
type 2 diabetes
.
Methods:
We conducted a case-control study in genotyping of five polymorphic loci, including
RAN
rs14035,
XPO5
rs11077,
DICER1
rs13078,
DICER1
rs3742330, and
TARBP2
rs784567, in miRNA processing genes to explore the risk factors for T2DM and diabetic vascular complications. Haplotype analyses, interactions of gene-gene and interactions of gene-environment were performed too.
Results:
We identified a 36% decreased risk of developing T2DM in individuals with the minor A allele in
DICER1
rs13078 (OR: 0.64; 95%CI: 0.42-0.95;
P
: 0.026). The AA haplotype in
DICER1
was also associated with a protective effect on T2DM compared with the AT haplotype (OR: 0.63; 95%CI: 0.42-0.94;
P
-value: 0.023). T2DM patients with the TT+TC genotype at
RAN
rs14035 had a 1.89-fold higher risk of developing macrovascular complications than patients with the CC genotype (OR: 1.89; 95%CI: 1.04-3.45;
P
-value: 0.037). We also identified two three-factor interaction models. One is a three-factor [
DICER1
rs13078, body mass index (BMI), and triglyceride (TG)] interaction model for T2DM (OR: 5.93; 95%CI: 1.25-28.26;
P
= 0.025). Another three-factor [
RAN
rs14035, hypertension (HP), and duration of T2DM (DOD)] interaction model was found for macrovascular complications of T2DM (
OR
= 41.60, 95%CI = 11.75-147.35,
P
< 0.001).
Conclusion:
Our study provides new evidence that two single nucleotide polymorphisms (SNPs) of the miRNA processing genes,
DICER1
and
RAN
, and their interactions with certain environmental factors might contribute to the risk of T2DM and its vascular complications in the southern Chinese population.
...
PMID:Association of Polymorphisms in miRNA Processing Genes With Type 2 Diabetes Mellitus and Its Vascular Complications in a Southern Chinese Population. 3135 28